相关实验视频
Updated: Jun 16, 2025
05:06
Bioluminescent Bacterial Imaging In Vivo
Published on: November 4, 2012
15.3K
利用失调的瘤代谢来准抗癌细菌
Akeem Santos1, Zeneng Wang1,2,3, Rashmi Bharti1
1Department of Cardiovascular & Metabolic Sciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, OH, USA.
Science advances
|June 13, 2025
概括
针对癌症代谢的工程细菌显示出改善的瘤特异性. 这种新的方法通过利用金氨酸积累来提高细菌癌症治疗的安全性和有效性.
科学领域:
- 微生物学 微生物学
- 在瘤学瘤学.
- 生物技术是生物技术.
背景情况:
- 细菌癌症治疗需要增强瘤特异性,以确保安全性和有效性.
- 瘤表现出改变的新陈代谢,包括增加的金氨酸,这是潜在的向机制.
研究的目的:
- 为了设计细菌,具体针对瘤,基于kynurenine积累.
- 开发一种具有改善瘤特异性和抗癌性能的新型细菌治疗药物.
主要方法:
- 基因工程 *Escherichia coli* 具有对金氨酸敏感调节剂 (KynR) 和促进剂.
- 优化了KynR表达,传送器活动和信号放大,用于Kynurenine检测.
- 经过修改的*Salmonella enterica*生长,使用基努瑞宁控制的电路进行细胞壁合成.
主要成果:
- 达到了对低微分子 kynurenine 水平的细菌反应.
- 在小鼠模型中,开发了基努瑞宁控制的*S. enterica* (AD95+),具有优越的瘤特异性.
- 在临床前模型中展示了AD95+抗癌特性.
结论:
- 针对瘤特异性kynurenine代谢的工程细菌显示出癌症治疗的希望.
- 与现有菌株相比,AD95+表现出增强的瘤向和治疗潜力.
- 这一战略为开发更安全,更有效的细菌癌症治疗提供了新的途径.
相关概念视频
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
02:53Adaptive Mechanisms in Cancer Cells
5.7K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.7K
02:50Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
01:27Tumor Immunotherapy
493
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
493
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K